SOURCES SOUGHT
66 -- Solvent Evaporator
- Notice Date
- 7/17/2014
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-14-1135526-SS
- Archive Date
- 8/7/2014
- Point of Contact
- Tiffany R. Williamson,
- E-Mail Address
-
tiffany.williamson@fda.hhs.gov
(tiffany.williamson@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Sources Sought Synopsis Notice to Small Businesses The purpose of this notice is to obtain information regarding the availability and capability of qualified small business concerns. The Food and Drug Administration intends to provide maximum practicable opportunities in its acquisitions to small businesses. The Food and Drug Administration (FDA) is conducting a market survey to assess the availability of small business firms as defined by NAICS code 334516 that has the capability to provide a Solvent Evaporator. This notification is for market research purposes and does not constitute a commitment, implied or otherwise, that a procurement will be accomplished. FDA welcomes responses from all interested parties. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted of FDA's use of such information. Acknowledgment of receipt of responses will not be made, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this sources sought with any interested parties. However, FDA reserves the right to contact vendors if additional information is required. Brand Name or Equal: This is a BRAND NAME OR EQUAL acquisition; in accordance with FAR 52.211-6, to be considered for award, offers of equal products must meet the salient physical, functional, or performance characteristics provided in the statement of requirements. In order to be considered an "equal" solution, any alternative solution proposed must be able to perform in strict accordance with the salient operational and technical features described below. Background The FDA Kansas City Dioxin Laboratory has 2 Accelerated Solvent Extractors (ASE) under software control which is used in a sample production mode for analysis of food samples and field samples for dioxin content. During the processing, each of the six samples in a batch will generate 200 mLs of solvent which contains the analyses desired. Currently each one of these samples must be manually transferred to a concentrator, solvent exchanged and concentrated. It must then be transferred again into a GC vial at a level of 10 microliters to be analyzed on the HRMS. There are at least four manual manipulations associated with this process, each of which is laborious, and affords multiple opportunities for contamination and sample loss. Since FDA operates at an ultra-trace level of quantitation, these are critical considerations. General Duties / Description of Work A consolidated evaporator for the use in the Kansas City Dioxin Laboratory is crucial for high-throughput and precision necessary for the dioxin program. An evaporator which couples with a Dionex ASE system which we are currently using in the Dioxins program is the most time-efficient and overall effective way to achieve this goal. This type of evaporator is more effective and roughly five times faster than our conventional sample evaporators. Our current sample workflow requires us to use three different concentrators after the ASE cleanup. By eliminating sample transfer steps, we expect to lower our dioxin background contamination levels while improving recovery rates. The evaporator we require must be capable of unattended operation which will allow us to focus on other tasks by spending minimal time and effort concentrating large-volume samples for chromatographic analysis. A two-stage cold trap built into the evaporator would allow for high levels of solvent recovery. Technical Requirements/Specification: Item # 1 - Qty: 1 Dionex ASE 350, Rocket Evaporator (Part # 088182) or Equal - Ability to concentrate or dry up to 18 ASE tubes - Seamless transition from ASE to concentration to autosampler vials - Built-in cold trap - Optimized software to control evaporation allowing for unattended operation - Ability to evaporate a variety of solvents and liquids, including dichloromethane, toluene, methanol, hexane and water - Deterrence of cross-contamination using precise sample temperature regulations - Include Recirculating chiller General Specifications: 1. The components and/or equipment shall be a newly manufactured, not used and refurbished, or previously used for demonstration. 2. The supplier will meet all the contract specifications listed above. 3. The supplier is to provide all tools, parts, labor, phone support and expertise as needed. Warranty: 1. Price should include a 12 month warranty agreement for all parts and labor. 2. The successful offeror shall provide maintenance and repair service. A toll-free telephone number for placing service calls is required. 3. Technician response shall be within 72 hours of a service call. Training: One day training for approximately 3 employees shall provide direct instruction required to interface the concentrator and determine the experimental parameters required in our specific case to allow concentration into GC vials. It shall provide instructional information for changing those parameters for future applications such as the fire retardants which are identified by FDA management as targets for analysis in food streams. This training will expedite the implementation of the concentrator into our production schedule, but will allow us to establish credentialing for the A2LA training requirements under which the lab operates. Shipping and Installation: 1. The system shall be delivered to the address below with all necessary supplies and accessories required for installation and start-up. 2. The offeror shall provide full system installation. Delivery Location US Food and Drug Administration Kansas City District Laboratory Attn: TBD 11510 W. 80th St. Lenexa, KS 66214 The instrument is to be delivered 30 days after award. General Instructions Contractors that believe they possess the ability to provide the required equipment must submit documentation of their ability to meet each of the characteristics listed above to the Contracting Officer (i.e. brochure, information on equipment that meets specifications, etc.) The capability statement must also include the organization name, type of business, DUNS number, point of contact name/telephone number/email address, and applicable NAICS code. Capability statements that do not provide sufficient information for assessment will be considered non-responsive. When submitting the information, please reference the solicitation number FDA-14-1135526-SS. Responses must be submitted via email to Tiffany Williamson at Tiffany.Williamson@fda.hhs.gov by 12:00 pm on July 23, 2014.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-14-1135526-SS/listing.html)
- Place of Performance
- Address: US Food and Drug Administration, Kansas City District Laboratory, Attn: TBD, 11510 W. 80th St., Lenexa, Kansas, 66214, United States
- Zip Code: 66214
- Zip Code: 66214
- Record
- SN03428780-W 20140719/140717235446-b4306c2589bf0a27f1501133d2a3aa8b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |